47762-0 |
Somatotropin^1H post dose insulin IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose insulin IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47762-0 |
|
|
|
|
Observation |
|
|
|
0 |
GH 1h p Ins IV SerPl-aCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p Ins IV; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47763-8 |
Somatotropin^1st specimen post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47763-8 |
|
|
|
|
Observation |
|
|
|
0 |
GH sp1 p chal SerPl-aCnc |
|
|
|
N |
|
Acute specimen; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; First; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp1; sp1 p chal; Spec; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47764-6 |
Somatotropin^2H post dose arginine |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose arginine |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47764-6 |
|
|
|
|
Observation |
|
|
|
0 |
GH 2h p Arg SerPl-aCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p Arg; After; Arbitrary concentration; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47765-3 |
Somatotropin^2H post dose glucose PO |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose glucose PO |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47765-3 |
|
|
|
|
Observation |
|
|
|
0 |
GH 2h p Glc PO SerPl-aCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p Glc; 2h p Glc PO; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47766-1 |
Somatotropin^2H post dose insulin IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose insulin IV |
|
MIN |
DefinitionDescription |
|
|
mIU/mL |
|
|
|
|
|
|
CHAL |
|
47766-1 |
|
|
|
|
Observation |
|
|
|
0 |
GH 2h p Ins IV SerPl-aCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p Ins IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47767-9 |
Somatotropin^2nd specimen post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47767-9 |
|
|
|
|
Observation |
|
|
|
0 |
GH sp2 p chal SerPl-aCnc |
|
|
|
N |
|
After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Convalescent; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp2; sp2 p chal; Spec; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47768-7 |
Somatotropin^30M post dose arginine |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose arginine |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47768-7 |
|
|
|
|
Observation |
|
|
|
0 |
GH 30M p Arg SerPl-aCnc |
|
|
|
N |
|
30M p Arg; After; Arbitrary concentration; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47769-5 |
Somatotropin^30M post dose glucose PO |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose glucose PO |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47769-5 |
|
|
|
|
Observation |
|
|
|
0 |
GH 30M p Glc PO SerPl-aCnc |
|
|
|
N |
|
30M p Glc; 30M p Glc PO; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
4777-9 |
HLA-B61(40) |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-B61(40) [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4777-9 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B61(40) Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47770-3 |
Somatotropin^30M post dose insulin IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose insulin IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47770-3 |
|
|
|
|
Observation |
|
|
|
0 |
GH 30M p Ins IV SerPl-aCnc |
|
|
|
N |
|
30M p Ins IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47771-1 |
Somatotropin^3H post dose glucose PO |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose glucose PO |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47771-1 |
|
|
|
|
Observation |
|
|
|
0 |
GH 3h p Glc PO SerPl-aCnc |
|
|
|
N |
|
3h p Glc; 3h p Glc PO; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47772-9 |
Somatotropin^45M post dose arginine |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose arginine |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47772-9 |
|
|
|
|
Observation |
|
|
|
0 |
GH 45M p Arg SerPl-aCnc |
|
|
|
N |
|
45M p Arg; After; Arbitrary concentration; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47773-7 |
Somatotropin^45M post dose insulin IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose insulin IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47773-7 |
|
|
|
|
Observation |
|
|
|
0 |
GH 45M p Ins IV SerPl-aCnc |
|
|
|
N |
|
45M p Ins IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47774-5 |
Somatotropin^pre dose arginine |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --pre dose arginine |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47774-5 |
|
|
|
|
Observation |
|
|
|
0 |
GH pre Arg SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Arg; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Pl; Plasma; Plsm; Point in time; pre Arg; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47775-2 |
Somatotropin^pre dose glucagon |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --pre dose glucagon |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47775-2 |
|
|
|
|
Observation |
|
|
|
0 |
GH pre Gc SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGF; HGH; Human growth hormone; Hyperglycemic factor; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47776-0 |
Somatotropin^pre dose glucose PO |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --pre dose glucose PO |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47776-0 |
|
|
|
|
Observation |
|
|
|
0 |
GH Pre Glc PO SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; Pl; Plasma; Plsm; Point in time; pre Glc; Pre Glc PO; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47777-8 |
Somatotropin^pre dose insulin IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --pre dose insulin IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47777-8 |
|
|
|
|
Observation |
|
|
|
0 |
GH pre Ins IV SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47778-6 |
Somatotropin^pre dose TRH |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --pre dose TRH |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
47778-6 |
|
|
|
|
Observation |
|
|
|
0 |
GH pre TRH SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Pl; Plasma; Plsm; Point in time; pre TRH; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
47779-4 |
Octadecanoate/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Octadecanoate (C18:0)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
47779-4 |
|
|
|
|
Both |
|
|
|
0 |
Octadecanoate/Creat Ur-sRto |
|
|
|
N |
|
1-Heptadecanecarboxylic acid; C18:0; C18H36O2; Cetylacetic acid; Chemistry; CR; Crea; Creat; Elaidate; Octadecanoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Stearate; Stearic acid; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.21 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
4778-7 |
HLA-B62(15) |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-B62(15) [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4778-7 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B62(15) Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47780-2 |
Sulfate |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Sulfate [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47780-2 |
|
|
|
|
Both |
|
|
|
0 |
Sulfate Ur-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Substance concentration; Sulf; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
47781-0 |
Sulfocysteine |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Sulfocysteine [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
47781-0 |
|
|
|
|
Both |
|
|
|
0 |
Sulfocysteine Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Cys(SO3H); Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47782-8 |
Taurine |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Taurine [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
47782-8 |
|
|
|
|
Both |
|
|
|
0 |
Taurine DBS-sCnc |
|
|
|
N |
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tau; WB; Whole blood |
2.7 |
2.21 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47783-6 |
Myristate/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Myristate (C14:0)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
47783-6 |
|
|
|
|
Both |
|
|
|
0 |
Myristate/Creat Ur-sRto |
|
|
|
N |
|
C14:0; Chemistry; CR; Crea; Creat; Myristic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Tetradecanoate; Tetradecanoic acid; UA; UCr; UR; Urn |
2.7 |
2.21 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
47784-4 |
Threonine |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Threonine [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
47784-4 |
|
|
|
|
Both |
|
|
|
0 |
Threonine DBS-sCnc |
|
|
|
N |
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Thr; WB; Whole blood |
2.73 |
2.21 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |